Quark Venture

Quark Venture is a Vancouver-based venture capital firm specializing in early-stage investments in the life sciences sector. The firm focuses on innovative biotechnology and health sciences companies with breakthrough technology platforms and projects. Quark Venture aims to address unmet medical needs through innovations in drug development, medical devices, health IT, and emerging convergent technologies.

The firm's investment strategy encompasses a broad range of stages, including Seed, Early Stage, Series A, Series B, Growth, Late Stage, and Pre-IPO. Geographically, Quark Venture has a diverse focus, investing in regions such as the United States, Canada, China, Europe, Africa, and Latin America. The industries targeted by the firm include Biotechnology, Health Sciences, Medical Devices, Health IT, and Emerging Technologies.

Quark Venture's portfolio includes investments in companies like SQZ Biotech, which is developing cell therapy platforms for various diseases. The firm has a history of significant investments, such as a $4 million investment in SQZ Biotech in 2016. Quark Venture's approach combines financial support with strategic guidance to help portfolio companies achieve their growth objectives and bring innovative solutions to the healthcare market.